NEW YORK — When Chiquita Brooks-LaSure, the Biden official who oversees the Medicare and Medicaid health insurance programs, sat down with New York government officials and reporters on Friday morning it was already, perhaps, a historic event.
“I don’t know if the CMS administrator has ever visited Washington Heights,” said Mark Levine, the Manhattan borough president.
Unfortunately, aside from the fact that the conversation was happening in the bustling neighborhood at Manhattan’s apex, little history was made. Instead there was broad agreement that high drug prices are a huge health problem, even if it isn’t clear what immediate steps can be taken to control them.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
